Lea Šolman

573 total citations
30 papers, 233 citations indexed

About

Lea Šolman is a scholar working on Dermatology, Surgery and Immunology and Allergy. According to data from OpenAlex, Lea Šolman has authored 30 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Dermatology, 8 papers in Surgery and 5 papers in Immunology and Allergy. Recurrent topics in Lea Šolman's work include Vascular Malformations and Hemangiomas (7 papers), Dermatology and Skin Diseases (5 papers) and Drug-Induced Adverse Reactions (4 papers). Lea Šolman is often cited by papers focused on Vascular Malformations and Hemangiomas (7 papers), Dermatology and Skin Diseases (5 papers) and Drug-Induced Adverse Reactions (4 papers). Lea Šolman collaborates with scholars based in United Kingdom, France and Slovenia. Lea Šolman's co-authors include Samira Syed, Kristyn Harman, Antonia Lloyd-Lavery, Natasha K Rogers, D. J. C. Grindlay, Kim S Thomas, Maria Gnarra, Mary Glover, Mark Wilkinson and Damir Kosutic and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Dermatology and Archives of Disease in Childhood.

In The Last Decade

Lea Šolman

20 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lea Šolman United Kingdom 8 113 74 40 38 27 30 233
N B Esterly United States 6 114 1.0× 30 0.4× 44 1.1× 26 0.7× 56 2.1× 9 265
Teresa S. Wright United States 9 71 0.6× 53 0.7× 15 0.4× 19 0.5× 30 1.1× 16 238
Charles B. Slonim United States 10 40 0.4× 63 0.9× 50 1.3× 39 1.0× 19 0.7× 23 286
Martha Ann McCarty United States 7 44 0.4× 72 1.0× 11 0.3× 19 0.5× 59 2.2× 9 248
Bruna Lavinas Sayed Picciani Brazil 10 38 0.3× 104 1.4× 36 0.9× 3 0.1× 47 1.7× 45 366
Semih Özbayrak Türkiye 10 50 0.4× 72 1.0× 3 0.1× 21 0.6× 46 1.7× 20 355
Ian Mackie United Kingdom 10 71 0.6× 30 0.4× 19 0.5× 3 0.1× 15 0.6× 26 282
Benjamin Burt United States 8 151 1.3× 46 0.6× 3 0.1× 52 1.4× 70 2.6× 14 266
Neil G. Dreizen United States 7 79 0.7× 99 1.3× 6 0.1× 51 1.3× 14 0.5× 8 315
Pietro Gentile Italy 7 60 0.5× 46 0.6× 3 0.1× 23 0.6× 11 0.4× 25 265

Countries citing papers authored by Lea Šolman

Since Specialization
Citations

This map shows the geographic impact of Lea Šolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Šolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Šolman more than expected).

Fields of papers citing papers by Lea Šolman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lea Šolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Šolman. The network helps show where Lea Šolman may publish in the future.

Co-authorship network of co-authors of Lea Šolman

This figure shows the co-authorship network connecting the top 25 collaborators of Lea Šolman. A scholar is included among the top collaborators of Lea Šolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lea Šolman. Lea Šolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Neill, Claire, et al.. (2024). PA09 Clinical characterization of a cohort of KRAS-associated low-flow vascular anomalies. British Journal of Dermatology. 191(Supplement_1). i126–i127.
2.
Bartram, Jack, et al.. (2024). P23 Successful Control of Systemic Mastocytosis Symptoms in a Two-Year-Old with Omalizumab. British Journal of Dermatology. 190(Supplement_1). i12–i12.
4.
Moraitis, Elena, et al.. (2023). P24 Recurrent skin ulcerations as an isolated manifestation of ISG15 deficiency. British Journal of Dermatology. 189(3). e50–e50.
5.
Daly, Aoife, et al.. (2023). Paediatric dermatology teleconsultations: a survey of healthcare professionals in the UK. Clinical and Experimental Dermatology. 48(7). 785–789. 1 indexed citations
6.
7.
Martinez, Anna E., et al.. (2021). Infantile haemangioma presenting in combination with a cerebriform naevus sebaceous on the scalp. Clinical and Experimental Dermatology. 47(1). 223–225.
8.
Lloyd-Lavery, Antonia, Lea Šolman, D. J. C. Grindlay, et al.. (2019). What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment. Clinical and Experimental Dermatology. 44(4). 376–380. 2 indexed citations
9.
Šolman, Lea, Antonia Lloyd-Lavery, D. J. C. Grindlay, et al.. (2019). What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention. Clinical and Experimental Dermatology. 44(4). 363–369. 15 indexed citations
10.
Lloyd-Lavery, Antonia, Lea Šolman, D. J. C. Grindlay, et al.. (2019). What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors. Clinical and Experimental Dermatology. 44(4). 370–375. 33 indexed citations
11.
Šolman, Lea, Mary Glover, Paula Beattie, et al.. (2018). Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. British Journal of Dermatology. 179(3). 582–589. 45 indexed citations
12.
Wilkinson, Mark, Lea Šolman, Pieter‐Jan Coenraads, & Carsten Goebel. (2018). Immediate hypersensitivity to p‐phenylenediamine. Contact Dermatitis. 80(3). 177–178. 6 indexed citations
13.
Šolman, Lea, et al.. (2017). Cutaneous Langerhans cell histiocytosis presenting in a neonate. Archives of Disease in Childhood. 103(10). 993–993. 3 indexed citations
14.
Gnarra, Maria, Lea Šolman, John Harper, & Samira Syed. (2015). Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome. British Journal of Dermatology. 173(1). 242–246. 11 indexed citations
15.
Šolman, Lea, et al.. (2014). Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol. Archives of Disease in Childhood. 99(12). 1132–1136. 25 indexed citations
16.
Kosutic, Damir, et al.. (2012). Complete mapping of lateral and medial sural artery perforators: Anatomical study with Duplex-Doppler ultrasound correlation. Journal of Plastic Reconstructive & Aesthetic Surgery. 65(11). 1530–1536. 30 indexed citations
17.
Kosutic, Damir, et al.. (2009). Preoperative antiseptics in clean/contaminated maxillofacial and oral surgery: prospective randomized study. International Journal of Oral and Maxillofacial Surgery. 38(2). 160–165. 26 indexed citations
18.
Jenkins, Rachel, et al.. (1976). Grain Disorder and its Influence on Emulsion Response. The Journal of Photographic Science. 24(1). 1–12. 1 indexed citations
19.
Šolman, Lea, et al.. (1973). The Computation of the Response of Model Emulsion Layers Part II Applications. The Journal of Photographic Science. 21(3). 118–124. 1 indexed citations
20.
Šolman, Lea, et al.. (1973). The Computation of the Response of Model Emulsion Layers Part I. Principles. The Journal of Photographic Science. 21(2). 93–100. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026